Prot #CDX0159-08: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The “EvolvE” Study)

Project: Research project

Project Details

StatusActive
Effective start/end date12/12/2312/12/26

Funding

  • Medpace Clinical Research LLC (Prot #CDX0159-08 // Prot #CDX0159-08)
  • Celldex Therapeutics, Inc. (Prot #CDX0159-08 // Prot #CDX0159-08)